Health Affairs, 23, no. 1 (2004): 52-63 doi: 10.1377/hlthaff.23.1.52 © 2004 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Abstract Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (16) Citing Articles via Google Scholar Google Scholar Articles by Carpenter, D. P. Search for Related Content PubMed PubMed Citation Articles by Carpenter, D. P. Related Collections Pharmaceuticals Research And Technology Politics Consumer Issues

The Political Economy Of FDA Drug Review: Processing, Politics, And Lessons For Policy

View larger version (29K): [in a new window]   EXHIBIT 2 Marginal Effects Of FDA Staff, Advocates’ Wealth, And Media Coverage On New Molecular Entity (NME) Approval Times

                      What's this?